Inhibition of Arterial Allograft Intimal Hyperplasia Using Recipient Dendritic Cells Pretreated with B7 Antisense Peptide

Table 1

MLR of T cells and recipient DCs with different treatment.

Groups	Final concentration of B7AP	Cpm
B7AP-pretreated ^C57BL/6aC3H/He DCs+T cells
Subgroup 1	100 mg/L	252±40
Subgroup 2	10 mg/L	236±36
Subgroup 3	1 mg/L	2239±316
Subgroup 4	1×10^−1 mg/L	2197±777
Subgroup 5	1×10^−2 mg/L	2097±150
Subgroup 6	1×10^−3 mg/L	2039±210
Subgroup 7	1×10^−4  mg/L	1935±79
Subgroup 8	1×10^−5 mg/L	2070±208
Untreated ^C57BL/6C3H/He DCs+T cells	0	2106±326
DCs without donor antigen + T cells	0	252±125
T cells alone	0	124±35